Registered Zambia · ZAMRA

Somo Care Powder for Injection

Isometadium Hydrochloride 125 mg

ZAMRA-HM-25-248 Injection 125 mg

What it does

Isometadium is a medication used to treat certain types of pain and discomfort.

Commonly used for: pain relief, muscle spasms, discomfort from various conditions

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
ZAMRA-HM-25-248
Registration date
2025-08-14
Expiry date
2030-08-13
Status
Registered/Compliant
Active ingredient
Isometadium Hydrochloride 125 mg
Dosage form
Injection
Strength
125 mg
Pack size
-
Therapeutic class
-
Country of origin
China
Manufacturer location
China, Chong Qing Shi, Rong Chang Qu, 昌州大道CJ5G+837 邮政编码: 402493

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:02:12 · updated 2026-10-01 03:34:30

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Isometadium is a medication used to treat certain types of pain and discomfort.

What it treats

  • pain relief
  • muscle spasms
  • discomfort from various conditions

How it works

Isometadium works by blocking pain signals in the body, helping to reduce the sensation of pain.

Who it's for

This medication is for individuals suffering from specific pain conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: isometadium

Isometadium is an opioid analgesic that acts primarily as a potent pain relief medication. It is derived from the morphinan class of opioids and is utilized mainly in the management of acute and chronic pain. Given its potency, isometadium is typically reserved for severe pain conditions when other analgesics are inadequate.

Indications

  • Severe acute pain
  • Chronic pain management
  • Postoperative pain relief

Dosage

Children: Refer to specialized pediatric guidelines or BNF for Children for appropriate dosing information in pediatric populations.

Adults: Refer to local guidelines or BNF for specific dosing recommendations, as it may vary based on clinical context and patient response.

Mechanism of action

Isometadium exerts its effects by binding to the mu-opioid receptors in the central nervous system, which leads to the inhibition of pain transmission and modulation of the pain response. This action results in analgesia, sedation, and euphoria, characteristic of opioid analgesics. Additionally, it may influence other neurotransmitter systems, contributing to its analgesic effects.

Pharmacodynamics

As a mu-opioid receptor agonist, isometadium produces its analgesic effects by altering the perception of pain at the spinal cord level and inhibiting the release of pro-nociceptive neurotransmitters. Its efficacy in pain management is dependent on dose and patient-specific factors, and it carries a risk of side effects commonly associated with opioids, including respiratory depression, constipation, and potential for dependence.

Pharmacokinetics

Isometadium is absorbed after parenteral administration, with peak plasma concentrations typically occurring shortly after administration. It is extensively metabolized in the liver, primarily via conjugation to glucuronides, with a moderate half-life that allows for effective pain management. The elimination of isometadium occurs via the kidneys, necessitating caution in patients with renal impairment.

Contra-indications

  • Hypersensitivity to isometadium or any of its components
  • Severe respiratory depression
  • Acute or severe bronchial asthma
  • Paralytic ileus
  • Concurrent use of monoamine oxidase inhibitors (MAOIs)

Adverse effects

  • Nausea
  • Vomiting
  • Constipation
  • Sedation
  • Respiratory depression
  • Hypotension
  • Dizziness
  • Euphoria
  • Dependence and addiction potential

Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines) may enhance sedative effects
  • MAOIs may increase the risk of severe adverse effects
  • Antihypertensive agents may have additive hypotensive effects
  • Concurrent use with other opioids can increase the risk of respiratory depression

Precautions

  • Use with caution in patients with a history of substance abuse
  • Monitor for signs of respiratory depression, especially in elderly patients
  • Caution in patients with impaired liver or renal function
  • Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms

Pregnancy

Use is contraindicated due to potential risks to the fetus. It is classified as a pregnancy category C drug.

Breast-feeding

Isometadium is excreted in breast milk. Caution is recommended if the drug is used by nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Injectable solution
  • Oral tablet

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.